Accelerate to discover

Back to filter

Related topics

Advances in Leukemia research using shear flow and Bioflux system

Fluxion Biosciences

May 24, 2022

Leukemia is a rare cancer with many subtypes. The production of abnormal leukocytes create disruptions in the immune...

In-vivo webinar: a versatile use of SPECT/CT in the development of theranostic tracers

MOLECUBES

Mar 9, 2022

Combining (preclinical) imaging and targeted therapy, is the basis of theranostics. In this webinar, Dr. Florea will...

Oct 1, 2022

Curiox webinar: Laminar Wash enables single-cell multiomics and cell hashing

Curiox

Oct 11, 2021

Professor Mats Bemark’s lab at the University of Gothenburg in Sweden studies how the immune system responds to...

Blood-Brain Barrier (BBB) - Pathophysiology in ischemic stroke

RWD

Aug 27, 2021

In-depth Understanding of Blood-Brain Barrier (BBB)

Micro-CT user meeting 2021

Bruker Biospin

Aug 19, 2021

Year after year, the Micro-CT User meeting showcases state-of-the-art applications in both life and material sciences,...

Oct 1, 2022

Predicting single-cell gene expression with imaging flow cytometry data and machine learning

Luminex

Aug 10, 2021

High-content imaging and single-cell genomics are two of the most prominent high-throughput technologies for studying...

Show all topics (10)

Studying cancer biology and therapeutic targets using PET technology: Preclinical imaging webinar

Jan 11, 2017

In vivo imaging is at the heart of preclinical research into cancer biology and treatment, with advances in technology delivering tools that are ever more powerful, accurate and easy-to-use. In this webinar, you will hear about one lab’s experience of integrating one such technology – Bruker’s preclinical PET system – into a hospital-based small-animal imaging lab, and how it has assisted their paradigm-shifting research into cancer cell biology.
This webinar is of interest for biomedical researchers, physicists, radio-pharmacists, radiochemists, radiologists, nuclear medicine doctors and technologists in the fields of oncology, cancer treatment, molecular imaging, metabolic processes, and preclinical imaging.
Join us at this webinar to learn more about these new experiences.

Register now

Webinar

Related technologies: PET, SPECT, CT

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 210 323 421

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Albira combines PET, SPECT and CT imaging in a unique and extremely powerful way

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey